EON Network: April 2025 Newsletter |
The EON Network was established to facilitate communication between exercise oncology and oncology nutrition researchers and clinicians to achieve our joint goal of improving cancer treatment outcomes.
The EON Network monthly newsletter includes upcoming webinars, updates on exercise oncology and oncology nutrition related events, publications that may be of interest, and resources. This information is also available on the EON Network webpage. Past newsletters are archived.
|
|
|
Thursday, May 22, 2025, 2-3 PM ET |
|
|
Colleen Spees, PhD, MEd, RDN, LD, FAND, FAHA
|
|
Food is Medicine in Oncology | Fang Fang Zhang, MD, PhD and Colleen Spees, PhD, MEd, RDN, LD, FAND, FAHA
This webinar will focus on the growing interest in integrating food and nutrition into health care, discussing the design of “food is medicine” interventions. It will discuss the preliminary findings and lessons learned from a medically tailored meals plus nutrition counseling intervention in improving the outcomes for vulnerable patients with lung cancer, along with opportunities for integrating food and nutrition into oncology care.
The EON webinar "Food is Medicine in Oncology" awards 1.0 CPEU for Commission on Dietetic Registration (CDR) credentialed practitioners in accordance with the Commission on Dietetic Registration’s CPEU Prior Approval Program.
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for physicians, physician assistants, and nurse practitioners.
Dr. Zhang is a nutritional epidemiologist and the Neely Family Professor at the Friedman School of Nutrition Science and Policy, Tufts University. Her research centers on characterizing dietary intake patterns, trends, and disparities in the population, investigating the role of nutrition in cancer prevention and control, and translating evidence into programs, practices, and policies.
Dr. Spees is a Professor in Medical Dietetics at The Ohio State University College of Medicine with advanced training in exercise science, health promotion, and nutritional genomics. Her primary focus of research involves developing, implementing, and testing biobehavioral lifestyle interventions aimed at providing optimal nutrition for vulnerable cancer populations. In this capacity, she seeks to improve access to culturally appropriate, health-promoting, and functional foods by impacting food availability, food access, food quality, and food use.
|
|
|
Spotlight: "Exercise May Improve Completion of Standard and Emerging Cancer Treatments."
|
|
|
Ignacio Catalá-Vilaplana, PhD
|
|
Catalá-Vilaplana I, Cao SE, Zadravec K, LeVasseur N, Kimple RJ, Lim AJ, Courneya KS, Campbell KL. Exercise may improve completion of standard and emerging cancer treatments. Exerc Sport Sci Rev 2025 Feb 18. Epub ahead of print. PMID: 39982316
Dr. Catalá-Vilaplana writes: "Receipt of full treatment dose as planned is considered a quality-of-care indicator in clinical oncology, but delivery of the target dose is not always achievable due to side effects such as diminished immune function, sarcopenia, or fatigue. New strategies to improve the ability of people being treated for cancer to better tolerate treatments and improve treatment completion should be a priority. Exercise during cancer treatment is associated with improved treatment completion, in part due to modulation of treatment toxicities and mitigation of muscle loss. This review suggests that exercise may improve treatment completion, particularly in esophagogastric and colorectal cancers undergoing chemotherapy. Promising results for ovarian and breast cancers have also been observed. Unified terminology and definitions for reporting on treatment completion outcomes are presented in this review in an effort to streamline future research in this field. As the field of exercise oncology continues to grow and efforts are made to incorporate exercise into standard care, consistent terminology will allow for better communication within the field and with clinicians."
|
|
|
Spotlight: "Effects of systemic anticancer treatment on cardiorespiratory fitness: a systematic review and meta-analysis."
|
|
|
|
Johansen SH, Wisløff T, Edvardsen E, Kollerud ST, Jensen JSS, Agwu G, Matsoukas K, Scott JM, Nilsen TS. Effects of systemic anticancer treatment on cardiorespiratory fitness: a systematic review and meta-analysis. JACC CardioOncol 2025;7(2):96-106. Epub 2025 Jan 14. PMID: 39967210
Dr. Nilsen writes: "Not only is assessment of cardiorespiratory fitness (CRF) a gold-standard marker for physical capacity, but it is also an independent predictor of numerous chronic diseases. Low CRF is associated with cancer and cardiovascular-specific, as well as all-cause mortality. It is well known that several systemic anticancer treatments (e.g., chemotherapy and endocrine therapy) are associated with side effects in several organs, crucial to CRF (e.g., the heart, blood, lungs, and skeletal muscle). Here, we conducted a systematic review and meta-analysis to evaluate the effects of systemic anticancer treatment on CRF in patients with adult-onset cancers.
"Across the 44 included studies, we found that systemic anticancer treatment was associated with a significant 8.8% decrease in CRF during treatment (weighted mean difference [WMD]: -2.13 mL O2 × kg-1 × min-1, 95% CI: -2.76 to -1.50). After a median of 2 years (range: 6 weeks to 12 years) post-therapy, VO2peak was significantly lower in cancer survivors (WMD: -6.39 mL O2 × kg-1 × min-1, 95% CI: -7.60; -5.18) compared to non-cancer controls.
"In summary, systemic anticancer therapy results in marked and persistent impairments in CRF. Our findings support the recommendations for exercise therapy to mitigate and reverse CFR decline during and after cancer treatment."
|
|
|
Additional Publications of Interest
|
Ulrich CM, Himbert C, Barnes CA, Boucher KM, Daniels B, Bandera VM, Ligibel JA, Wetter DW, Hess R, Kim J, Lundberg K, Mitzman B, Marcus R, Finlayson SRG, LaStayo PC, Varghese TK Jr. Precision exercise effect on fatigue and function in lung cancer surgery: a randomized clinical trial. JAMA Surg 2025 Mar 12:e250130. Epub ahead of print. PMID: 40072448
Brown JC, Compton SLE, Kang A, Jayaraman A, Gilmore LA, Kirby BJ, Greenway FL, Yang S, Spielmann G. Effects of exercise on inflammation, circulating tumor cells, and circulating tumor DNA in colorectal cancer. J Sport Health Sci 2025 Mar 17:101036. Epub ahead of print. PMID: 40107449
Kearney N, Connolly D, Bahramian K, Guinan E. Strategies to improve participation in exercise programmes during chemotherapy: a modified nominal group technique. J Cancer Surviv 2025 Mar 7. Epub ahead of print. PMID: 40053257
Papadopoulos E, Brick R, Sirois A, Beauplet B, Wood KC, Furness H, Barrett C, Ward A, Murphy J, Pattwell M, Navarrete EC, Williams K, Haase K. Perspectives on prehabilitation for older adults with cancer: A report from the International Society of Geriatric Oncology (SIOG) rehabilitation group. J Geriatr Oncol 2025;16(3):102224. Epub ahead of print. PMID: 40096764
Gany FM. Call to action for treatment of food insecurity: a vital element of equitable cancer care. JCO Oncol Pract 2025 Mar 20:OP2500092. Epub ahead of print. PMID: 40112260
|
|
|
| Call for Papers: Supportive Care in Cancer Special Issue on Cancer-related Fatigue |
|
|
Drs. Nicolas Hart and Amber Kleckner are leading a special issue of Supportive Care in Cancer on cancer-related fatigue.
This series on cancer-related fatigue focuses on the full spectrum of studies that may improve outcomes for people affected by cancer experiencing cancer-related fatigue. This may include prevention, screening, assessment, diagnosis, interventions, self-management support, and models of care to enhance clinical management, health service performance, and implementation science strategies.
Supportive Care in Cancer is published by Springer in a hybrid format, meaning that you can select "subscription-based," so authors do not have to pay a Article Processing Charges (APC), or "open access," in which the article will be freely available online to everyone.
|
|
|
|
Call for Papers: JNCI Cancer Spectrum Special Collection |
|
|
JNCI Cancer Spectrum is calling for papers investigating how exercise and nutrition impact cancer outcomes. Studies that involve clinical trials or prospective data collection over papers that are exploratory and analyze existing data for statistical associations without a well-considered biological mechanism are particularly encouraged. All manuscript types will be considered. Accepted papers will be published normally on advance access and moved into the open issue but also housed in a special collection on the journal website. The deadline for submissions is September 1, 2025.
Please consider submitting your own work to the journal and sharing this announcement with your colleagues.
|
|
|
|
Call for Papers: Journal of the Academy of Nutrition and Dietetics Theme Issue |
|
|
The Journal of the Academy of Nutrition and Dietetics (JAND) is pleased to announce a Theme Issue focused on nutrition and cancer. There is great scientific interest in this topic from the discovery of the role of various nutrients, dietary patterns and nutritional status on cancer prevention, control and survivorship to the development and testing of interventions, as well as the implementation and dissemination of nutrition oncology science to stakeholders. This Theme Issue is an opportunity for the research and clinical communities to draw together high-quality original research and reviews that advance our understanding of nutrition and cancer.
Submissions on nutrition and cancer should address populations of interest including (but not limited to):
• The study of populations at risk (low, moderate or high risk) for diet-associated cancers;
• Oncology patients (active treatment) as well as longer-term survivors;
• Patients experiencing or at risk for treatment-related sequalae;
• Caregivers of patients experiencing a cancer diagnosis; and
• Health care providers serving oncology patients.
Submission to this Theme Issue is by pre-approval only. Authors who are interested in submitting an article for this Theme Issue are required to submit an abstract (up to 300 words) to Dr. Wendy Demark-Wahnefried (demark@uab.edu) and Dr. Cynthia Thomson (cthomson@arizona.edu) by August 31, 2025. For all submissions that include research data, this abstract must include: Background, Objective, Design, Participants/Setting, Intervention (if applicable), Main Outcome Measures, Analyses Performed, anticipated or measured Results, and Conclusions, consistent with JAND’s Manuscript Preparation Guidelines. For narrative reviews, this abstract should be in continuous text. Only after abstract review by journal editors, will authors be notified of their invitation to submit a full manuscript to this Theme Issue.
Deadlines:
• Open for abstracts: NOW
• Abstract deadline: 31 August 2025
• Invitations to submit a full article sent out by 1 October 2025
• Full articles due: 15 December 2025
• Theme Issue published October 2026 (subject to change)
|
|
|
NIH/NCI Funding Opportunities |
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
6110 Executive Blvd Suite 750 | Rockville, MD 20852 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
| |
|
|
